Monterey Bio Acquisition Stock Debt To Equity
Monterey Bio Acquisition fundamentals help investors to digest information that contributes to Monterey Bio's financial success or failures. It also enables traders to predict the movement of Monterey Stock. The fundamental analysis module provides a way to measure Monterey Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monterey Bio stock.
Monterey |
Monterey Bio Acquisition Company Debt To Equity Analysis
Monterey Bio's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Monterey Bio Debt To Equity | 7.37 % |
Most of Monterey Bio's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monterey Bio Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Monterey Bio Acquisition has a Debt To Equity of 7.372%. This is 77.55% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The debt to equity for all United States stocks is 84.86% higher than that of the company.
Monterey Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monterey Bio's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monterey Bio could also be used in its relative valuation, which is a method of valuing Monterey Bio by comparing valuation metrics of similar companies.Monterey Bio is currently under evaluation in debt to equity category among its peers.
Monterey Fundamentals
| Number Of Shares Shorted | 29.57 K | |||
| EBITDA | (2.04 M) | |||
| Net Income | (1.27 M) | |||
| Cash And Equivalents | 6.76 K | |||
| Total Debt | 175.41 K | |||
| Debt To Equity | 7.37 % | |||
| Current Ratio | 25.00 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1 M) | |||
| Total Asset | 21.42 M | |||
| Retained Earnings | (1.86 M) | |||
| Working Capital | (1.29 M) | |||
| Z Score | -0.51 | |||
| Net Asset | 21.42 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Monterey Stock
If you are still planning to invest in Monterey Bio Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Monterey Bio's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |